StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Abbott Laboratories
NYSE:ABT
Sector
Location
Market Cap
USD 233.90 B
Share Price
USD 134.44
Avg Daily Volume
7,103,166
Change (1 day)
0.25%
Change (1 year)
31.38%
Change (YTD)
18.86%
Abbott Laboratories Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 24.38
Abbott Laboratories Revenue Per Share is USD 24.38 for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.00% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Abbott Laboratories Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 23.22, a -2.45% change year over year.
-
Abbott Laboratories Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 23.80, a -5.68% change year over year.
-
Abbott Laboratories Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 25.23, a 19.81% change year over year.
-
Abbott Laboratories Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 21.06, a 15.95% change year over year.
Competitors
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.46
603392.SS
-0.14
-1.57%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Indegene Limited
USD 6.64
INDGN.NS
+0.01
0.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.46
603392.SS
-0.14
-1.57%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
Indegene Limited
USD 6.64
INDGN.NS
+0.01
0.16%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%